INTERNATIONAL PATENT: VIGIL NEUROSCIENCE, INC. FILES APPLICATION FOR "HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE"

GENEVA, June 25 -- VIGIL NEUROSCIENCE, INC. (100 Forge Road, Suite 700Watertown, Massachusetts 02472) filed a patent application (PCT/US2024/059814) for "HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE" on Dec 12, 2024. With publication no. WO/2025/128848, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOUZE, Jonathan B. (c/o Vigil Neuroscience, Inc.100 Forge Road, Suite 700Watertown, Massachusetts 02472), PANDYA, Bhaumik (c/o Vigil Neuroscience, Inc.100 Forge Road, ...